fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Pfizer Ltd

Pfizer Ltd

Updated on July 31, 2020

Stock/Share Code - PFIZER

Pfizer is engaged in manufacturing, marketing, trading and export of pharmaceutical products.(Source : 201903 Annual Report Page No: 131)

Below is the details of PFIZER Pfizer Ltd

Market Cap₹18,476 Cr.
Current Price ₹4,389.95 as on 6 Aug 20
52 Week High / Low Price₹5,172.95 / ₹2,792.25
Face Value₹10
Stock P/E35.83
Book Value₹689.89
Dividend Yield0.56 %
ROCE23.22 %
ROE15.07 %
Sales Growth (3yrs)1.13 %
SectorPharmaceuticals
IndustryPharmaceuticals - Multinational
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company is virtually debt free. Company has been maintaining a healthy dividend payout of 25.52%
Cons: Company has a low return on equity of 13.56% for last 3 years.

Pfizer Ltd Price Chart

Pfizer Ltd Price Chart

Pfizer Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Abbott India ₹263.65 59.71 ₹35,537.23 Cr. 0.30 ₹186.69 Cr. 59.50 13.78 1078.25 37.36
2. Glaxosmi. Pharma ₹48.05 55.82 ₹23,197.62 Cr. 1.46 ₹138.07 Cr. -2.34 3.33 775.80 31.11
3. Pfizer 35.83 ₹18,475.68 Cr. 0.56 ₹139.06 Cr. 5.40 4.75 538.18 23.22
4. Sanofi India ₹8,174.9 37.29 ₹17,808.18 Cr. 1.37 ₹85.4 Cr. 24.62 9.37 784.50 28.84
5. Astrazeneca Phar ₹3,341.3 105.68 ₹7,632.5 Cr. 0.03 ₹9.58 Cr. -2.44 2.42 194.90 26.51
6. Proc. Gam. Heal. ₹120.7 41.48 ₹6,823.18 Cr. 0.58 ₹46.46 Cr. 14.12 -1.26 228.11 78.16
7. Novartis India ₹263.65 62.00 ₹1,415.4 Cr. 1.74 ₹7.73 Cr. -39.94 -13.39 117.46 7.58

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Pfizer Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019
Sales -438421571457520512520514536544567538
YOY Sales Growth %-14.52%-16.02%6.63%-7.09%18.69%21.71%-8.99%12.54%3.02%6.26%9.10%4.75%
Expenses -343344404339381382390359385378403405
Material Cost %36.88%33.92%41.92%35.79%37.33%36.00%39.04%34.41%34.31%35.09%36.93%37.31%
Employee Cost %13.67%19.19%13.89%14.37%17.04%15.74%15.01%16.29%15.21%16.10%15.21%16.72%
Operating Profit9577167118138130130154151166164133
OPM %22%18%29%26%27%25%25%30%28%31%29%25%
Other Income292724323131376435364558
Interest0000-00001232
Depreciation161516181718181818252525
Profit before tax10789175132153142149201168175181164
Tax %36%35%36%34%31%35%36%34%35%36%15%15%
Net Profit6857111871059296132109113154139
EPS in Rs14.8712.5024.2919.0722.8420.0720.9428.8423.9324.6633.7230.40
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Nov 2007Nov 2008Nov 2009Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019TTM
Sales -6726747721,2521,0931,0491,1121,8532,0121,9661,9692,0822,185
Sales Growth %1.81%0.36%14.57%62.18%-12.71%-4.07%5.99%66.66%8.63%-2.29%0.11%5.74%
Expenses -5555496449838978658721,4381,5791,6161,4681,5161,570
Material Cost %34.46%35.25%37.26%31.18%32.85%31.76%33.72%39.94%39.11%40.51%37.58%35.93%
Manufacturing Cost %4.73%4.84%6.28%6.00%5.92%6.07%5.67%4.43%3.76%3.92%3.50%3.55%
Employee Cost %15.14%15.60%18.14%18.37%17.67%20.16%17.28%12.78%13.81%15.49%16.00%15.60%
Other Cost %28.24%25.72%21.75%22.93%25.57%24.45%21.80%20.50%21.80%22.27%17.49%17.74%
Operating Profit117125128270197184239414433350501566615
OPM %17%19%17%22%18%18%22%22%22%18%25%27%28%
Other Income3433049089925191094497232114167174
Interest0002221212128
Depreciation101181210882505863667192
Profit before tax450419210345278694340207470517548660689
Tax %25%29%35%34%33%27%35%66%35%35%34%35%
Net Profit33929913722618550322170305337360429516
EPS in Rs108.9198.1243.7554.8859.84163.0912.8312.7266.6673.6178.7093.78112.71
Dividend Payout %24%12%27%22%20%19%486%82%22%27%25%24%

Compounded Sales Growth

  • 10 Years:: 11.94%
  • 5 Years:: 13.37%
  • 3 Years:: 1.13%
  • TTM:: 5.79%

Compounded Profit Growth

  • 10 Years:: 10.87%
  • 5 Years:: 14.32%
  • 3 Years:: 12.77%
  • TTM:: 21.58%

Return on Equity

  • 10 Years:: 14.38%
  • 5 Years:: 13.62%
  • 3 Years:: 33.74%
  • 1 Year:: 27.02%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Nov 2007Nov 2008Nov 2009Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Sep 2019
Share Capital -30303030303030464646464646
Equity Capital29.8429.8429.8429.8429.8429.8429.8445.7545.7545.7545.7545.75
Reserves6198709641,1341,2751,6656291,9272,1182,3732,6372,9663,110
Borrowings0000000222222
Other Liabilities -2181972092232773653186387228401,004926970
Trade Payables9210711698136151160334338388496436381
Advance from Customers0000000299154180179
Other liability items1268993125141214158302285297329311589
Total Liabilities8671,0961,2031,3861,5822,0609772,6142,8883,2613,6903,9404,128
Fixed Assets -60519236312620944925902950886973
Gross Block1421401881181181161151,2899811,0211,1331,138
Accumulated Depreciation8189958287909534456119182252
CWIP10321200313315102
Investments0004948464443370000
Other Assets -7961,0131,1101,3001,5021,9889091,6141,9232,3432,7393,0543,153
Inventories95125113159183165152388361322297387317
Trade receivables616064100142142173160142110155172207
Cash Equivalents4805435275788661,4333086091,0251,5231,7721,9142,025
Loans n Advances1612884083711781048717219418526931938
Other asset items-2-3-491133143189285202204246262566
Total Assets8671,0961,2031,3861,5822,0609772,6142,8883,2613,6903,9404,128

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Nov 2007Nov 2008Nov 2009Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Cash from Operating Activity -17237758024-1613211334532933298
Profit from operations169161176282208195252299451363515580
Receivables2-7-18-53-59-34-14-342718-45-19
Inventory3-3012-46-24-1414-79273925-91
Payables-3829133221391583061110-59
Direct taxes-113-127-103-149-122-208-124-145-174-183-194-238
Other operating items0071606-10-111531-79-76
Exceptional CF items-7211-11-3-00000000
Cash from Investing Activity -232-79-475727862610368-701-250-23835
Fixed assets purchased-14-27-19-7-3-1-4-21-44-25-103-4
Fixed assets sold28021104242097913331
Investments purchased-67-108-91000000000
Subsidy received0000032000000
Investment income000000009477
Interest received3354628581769839567990121
Invest in subsidiaries0000-00000000
Inter corporate deposits000-2119987000000
Other investing items001007649-819-399-266-119
Cash from Financing Activity --76-95-43-86-14-43-1,360-1-62-83-110-110
Interest paid fin-000000000000
Dividends paid-76-95-43-86-14-21-1,161-1-50-69-92-91
Other financing items00000-23-1990-12-14-19-19
Net Cash Flow17363-1651288567-1,125181-417-3-1723

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Nov 2007Nov 2008Nov 2009Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
ROCE %37%27%23%32%23%19%29%24%22%17%21%23%
Debtor Days333230294749573226202930
Inventory Turnover6.946.146.499.196.386.027.026.875.385.766.366.09

Announcements & News

Recent Announcements

Annual Reports

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Pfizer Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.